| 2026-10-20 | Resumed | JP Morgan | Neutral |
| 2026-09-10 | Resumed | Stifel | Hold |
| 2026-07-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-03-24 | Eingeleitet | Truist | Buy |
| 2026-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-12-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-10-17 | Resumed | BofA Securities | Underperform |
| 2023-10-06 | Resumed | Goldman | Buy |
| 2023-03-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-01-09 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-12-09 | Eingeleitet | Citigroup | Neutral |
| 2022-09-29 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-05-02 | Resumed | Truist | Buy |
| 2021-09-28 | Resumed | BofA Securities | Buy |
| 2021-07-16 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2021-02-16 | Hochstufung | Truist | Hold → Buy |
| 2021-01-11 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-21 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-10 | Eingeleitet | Goldman | Buy |
| 2020-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-04-02 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-03-24 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-03-11 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-02-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-02-10 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2020-01-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-01-06 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-12-13 | Eingeleitet | SunTrust | Hold |
| 2019-09-03 | Resumed | Jefferies | Buy |
| 2019-08-19 | Resumed | Barclays | Overweight |
| 2019-08-19 | Bestätigt | BofA/Merrill | Buy |
| 2019-08-14 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-06-11 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-06-10 | Eingeleitet | BMO Capital Markets | Market Perform |